Definitive Healthcare Corp (DH)vsNovartis AG ADR (NVS)
DH
Definitive Healthcare Corp
$0.96
-6.57%
HEALTHCARE · Cap: $108.62M
NVS
Novartis AG ADR
$148.34
+1.95%
HEALTHCARE · Cap: $275.95B
Smart Verdict
WallStSmart Research — data-driven comparison
Novartis AG ADR generates 23326% more annual revenue ($56.58B vs $241.52M). NVS leads profitability with a 23.9% profit margin vs -57.5%. NVS earns a higher WallStSmart Score of 51/100 (C-).
DH
Hold37
out of 100
Grade: F
NVS
Buy51
out of 100
Grade: C-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+84.5%
Fair Value
$10.92
Current Price
$0.96
$9.96 discount
Margin of Safety
-52.0%
Fair Value
$109.95
Current Price
$148.34
$38.39 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Mega-cap, among the largest globally
Every $100 of equity generates 35 in profit
Strong operational efficiency at 30.5%
Keeps 24 of every $100 in revenue as profit
Generating 2.9B in free cash flow
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
ROE of -40.4% — below average capital efficiency
Revenue declined 1.2%
Grey zone — moderate risk
Expensive relative to growth rate
Revenue declined 0.7%
Earnings declined 9.3%
Comparative Analysis Report
WallStSmart ResearchBull Case : DH
The strongest argument for DH centers on Price/Book.
Bull Case : NVS
The strongest argument for NVS centers on Market Cap, Return on Equity, Operating Margin. Profitability is solid with margins at 23.9% and operating margin at 30.5%.
Bear Case : DH
The primary concerns for DH are EPS Growth, Market Cap, Return on Equity.
Bear Case : NVS
The primary concerns for NVS are Altman Z-Score, PEG Ratio, Revenue Growth.
Key Dynamics to Monitor
DH profiles as a turnaround stock while NVS is a declining play — different risk/reward profiles.
DH carries more volatility with a beta of 1.34 — expect wider price swings.
NVS is growing revenue faster at -0.7% — sustainability is the question.
NVS generates stronger free cash flow (2.9B), providing more financial flexibility.
Bottom Line
NVS scores higher overall (51/100 vs 37/100), backed by strong 23.9% margins. DH offers better value entry with a 84.5% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Definitive Healthcare Corp
HEALTHCARE · HEALTH INFORMATION SERVICES · USA
Definitive Healthcare Corp (DH) is a premier provider of data and analytics solutions tailored for the healthcare sector, serving a wide array of clients including pharmaceutical firms, payers, and healthcare providers. By leveraging extensive datasets and real-time analytics, the company enhances operational performance and provides strategic insights that lead to improved patient outcomes. In an environment marked by increasing complexity and demand for healthcare analytics, Definitive Healthcare is strategically positioned to deliver innovative solutions that drive operational excellence and competitive advantage for its partners. With a commitment to enhancing healthcare delivery through data-driven insights, DH is at the forefront of transforming the healthcare landscape.
Visit Website →Novartis AG ADR
HEALTHCARE · DRUG MANUFACTURERS - GENERAL · USA
Novartis AG researches, develops, manufactures and markets medical devices worldwide. The company is headquartered in Basel, Switzerland.
Visit Website →Compare with Other HEALTH INFORMATION SERVICES Stocks
Want to dig deeper into these stocks?